J. Baum

Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retrospective Study by the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium

H. Gabra, I. Vergote, J. Sehouli, 2022, Annals of Surgical Oncology.

Impact of clinical factors and surgical outcome on long-term survival in high-grade serous ovarian cancer: a multicenter analysis

I. Vergote, S. Darb-Esfahani, N. Concin, 2021, International Journal of Gynecological Cancer.

Secondary malignancies in long-term ovarian cancer survivors: results of the ‘Carolin meets HANNA’ study

J. Sehouli, E. Braicu, H. Woopen, 2021, International Journal of Gynecological Cancer.

764P Survey on the practical implementation of BRCA gene and HRD-testing and PARP-inhibitor management in Germany: A national NOGGO/JAGO-AGO intergroup study

J. Sehouli, C. Fotopoulou, E. Braicu, 2021, Annals of Oncology.

Survey on implementation of molecular testing in ovarian cancer and PARP inhibitor: a national North-Eastern German Society of Gynecologic Oncology/Young Academy of Gynecologic Oncology/Arbeitsgemeinschaft Gynäkologische Onkologie intergroup analysis

J. Sehouli, C. Fotopoulou, R. Chekerov, 2022, International Journal of Gynecological Cancer.

Olaparib in an ovarian cancer patient with end-stage renal disease and hemodialysis

J. Sehouli, E. Braicu, R. Richter, 2023, Cancer Chemotherapy and Pharmacology.